Get the App
A

Aurinia (AUPH)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aurinia (AUPH)

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more

  • 4.76
  • 4.88
  • 4.64
  • 24.45
  • -7.2%
  • 166M
  • 0.00
  • 2.38M
  • 725M
  • 4.49
  • -75%
  • %

Stock News

Need to Know: BlackRock says the market is misjudging these key risks. Here’s its advice on stocks and bonds.

31 minutes ago

Need to Know: BlackRock says the market is misjudging these key risks. Here’s its advice on stocks and bonds.

MarketWatch

: More than half of renters think they’ll never be able to own a home, survey says. Here’s why.

1 hour ago

: More than half of renters think they’ll never be able to own a home, survey says. Here’s why.

MarketWatch

: Women need to save more, earlier and invest more aggressively for retirement – here’s why

1 hour ago

: Women need to save more, earlier and invest more aggressively for retirement – here’s why

MarketWatch

Surviving Covid Was Just the Beginning of the Battle

1 hour ago

Surviving Covid Was Just the Beginning of the Battle

Bloomberg

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium